ArticleAmerican journal of cardiovascular disease2017

Ejection fraction improvement and reverse remodeling achieved with Sacubitril/Valsartan in heart failure with reduced ejection fraction patients.

Aws Almufleh et al.PubMed ↗Full text ↗

No numbers read from the abstract.